112 related articles for article (PubMed ID: 24694639)
1. Risk of CNS dissemination in extranodal lymphomas.
Ferreri AJ
Lancet Oncol; 2014 Apr; 15(4):e159-69. PubMed ID: 24694639
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis, prevention and treatment of central nervous system involvement in peripheral t-cell lymphomas.
Zing N; Fischer T; Federico M; Chiattone C; Ferreri AJM
Crit Rev Oncol Hematol; 2021 Nov; 167():103496. PubMed ID: 34653598
[TBL] [Abstract][Full Text] [Related]
4. Primary extranodal B-cell lymphoma: current concepts and treatment strategies.
Vannata B; Zucca E
Chin Clin Oncol; 2015 Mar; 4(1):10. PubMed ID: 25841717
[TBL] [Abstract][Full Text] [Related]
5. The risk of CNS involvement in aggressive lymphomas in the rituximab era.
Benevolo G; Chiappella A; Vitolo U
Expert Rev Hematol; 2013 Dec; 6(6):643-52. PubMed ID: 24168678
[TBL] [Abstract][Full Text] [Related]
6. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
Herrlinger U; Glantz M; Schlegel U; Gisselbrecht C; Cavalli F
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S25-34. PubMed ID: 19660681
[TBL] [Abstract][Full Text] [Related]
7. CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature.
Buckstein R; Lim W; Franssen E; Imrie KL
Leuk Lymphoma; 2003 Jun; 44(6):955-62. PubMed ID: 12854893
[TBL] [Abstract][Full Text] [Related]
8. Primary CNS lymphoma.
Batchelor T; Loeffler JS
J Clin Oncol; 2006 Mar; 24(8):1281-8. PubMed ID: 16525183
[TBL] [Abstract][Full Text] [Related]
9. [AIDS-related non-Hodgkin lymphomas. Clinical picture and prognosis].
Penkowa M; Hansen PB
Ugeskr Laeger; 1998 Apr; 160(18):2685-8. PubMed ID: 9599550
[TBL] [Abstract][Full Text] [Related]
10. Prevention of CNS relapse in diffuse large B-cell lymphoma.
Kridel R; Dietrich PY
Lancet Oncol; 2011 Dec; 12(13):1258-66. PubMed ID: 21933751
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma: immunohistochemical profile and prognostic significance.
Raoux D; Duband S; Forest F; Trombert B; Chambonnière ML; Dumollard JM; Khaddage A; Gentil-Perret A; Péoc'h M
Neuropathology; 2010 Jun; 30(3):232-40. PubMed ID: 19925562
[TBL] [Abstract][Full Text] [Related]
13. Aggressive Non-Hodgkin lymphomas: risk factors and treatment of central nervous system recurrence.
Santambrogio E; Nicolosi M; Vassallo F; Castellino A; Novo M; Chiappella A; Vitolo U
Expert Rev Hematol; 2019 Sep; 12(9):787-796. PubMed ID: 31305170
[No Abstract] [Full Text] [Related]
14. Treatment of AIDS-related lymphomas.
Sparano JA
Curr Opin Oncol; 1995 Sep; 7(5):442-9. PubMed ID: 8541390
[TBL] [Abstract][Full Text] [Related]
15. Secondary central nervous system lymphoma: risk factors and prophylaxis.
Montoto S; Lister TA
Hematol Oncol Clin North Am; 2005 Aug; 19(4):751-63, viii. PubMed ID: 16083835
[TBL] [Abstract][Full Text] [Related]
16. How I treat patients with aggressive lymphoma at high risk of CNS relapse.
Chin CK; Cheah CY
Blood; 2017 Aug; 130(7):867-874. PubMed ID: 28611025
[TBL] [Abstract][Full Text] [Related]
17. Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.
van Besien K; Gisselbrecht C; Pfreundschuh M; Zucca E
Leuk Lymphoma; 2008; 49 Suppl 1():52-8. PubMed ID: 18821433
[TBL] [Abstract][Full Text] [Related]
18. Treatment and prevention of secondary CNS lymphoma.
Nagpal S; Glantz MJ; Recht L
Semin Neurol; 2010 Jul; 30(3):263-72. PubMed ID: 20577933
[TBL] [Abstract][Full Text] [Related]
19. Prevention of central nervous system relapses in diffuse large B-cell lymphoma: which patients and how?
Korfel A
Curr Opin Oncol; 2011 Sep; 23(5):436-40. PubMed ID: 21760506
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A
Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
